Market Overview

Global Transplant Diagnostics Market Size, Share & Trends Analysis Report 2018-2024

Share:

Global Transplant Diagnostics Market Size, Share & Trends Analysis Report 2018-2024

PR Newswire

DUBLIN, Aug. 31, 2018 /PRNewswire/ --

Research and Markets Logo. (PRNewsFoto/Research and Markets) (PRNewsfoto/Research and Markets)

The "Transplant Diagnostics Market Size, Share & Trends Analysis Report By Technology (Molecular Assays, Non-Molecular Assays), By Product (Reagents & Consumables, Instruments), And Segment Forecasts, 2018 - 2024" report has been added to ResearchAndMarkets.com's offering.

The global transplant diagnostics market size is expected to reach USD 895.2 million by 2024 It is projected to expand at a CAGR of 7.6% over the forecast period.

Increasing number of patients suffering from chronic diseases frequently leading to organ failure is creating an upsurge in demand for transplant procedures. In addition, adoption of stem cell therapy and personalized medicine is escalating, thereby influencing demand for transplant diagnostics.

Risks and complexities associated with organ transplants necessitate the need for improved and sophisticated diagnostic tools. Next-Generation Sequencing (NGS) technology is rapidly replacing traditional diagnostic methods, such as serological techniques employed in Human Leukocyte Antigen (HLA) typing, owing to growing demand for high-throughput diagnostic tools with enhanced accuracy.

Market growth is expected to be restrained by factors such as reimbursement controversies and ethical issues in some parts of the world. In addition, high cost of performing HLA matching using Polymerase Chain Reaction (PCR) and NGS devices is challenging the growth of the transplant diagnostics market in developing countries.

Key Findings

  • PCR-based molecular assay captured the largest share in the overall market in 2016 due to extensive adoption in HLA typing
  • The sequencing-based typing segment is anticipated to witness significant growth from 2016 to 2024. High adoption of NGS is a major factor driving segment growth
  • In 2016, the reagents and consumables segment accounted for the largest market share attributed to repeat purchase
  • North America captured the largest revenue share in 2016 and is expected to maintain its dominance throughout the forecast period due to well-established research infrastructure, increasing healthcare expenditure, high adoption of advanced diagnostic techniques, and growing R&D activities
  • Asia Pacific is expected to witness significant growth during the forecast period owing to expanding research opportunities, healthcare expenditure, medical tourism industry, and awareness regarding organ donation

Key Topics Covered

Chapter 1 Research Methodology
1.1 Information procurement
1.2 Data Analysis
1.3 Approaches for market estimation

Chapter 2 Executive Summary
2.1 Market Snapshot

Chapter 3 Transplant Diagnostics Market Variables, Trends & Scope
3.1 Market segmentation & scope
3.2 Market Driver Analysis
3.3 Market Restraints Analysis
3.4 Penetration & growth prospect mapping
3.5 Transplant Diagnostics - SWOT Analysis, By Factor (political & legal, economic and technological)
3.6 Industry Analysis - Porter's

Chapter 4 Transplant Diagnostics Market: Technology Estimates & Trend Analysis
4.1 Transplant diagnostics market: technology movement analysis
4.2 Molecular
4.3 Non Molecular

Chapter 5 Transplant Diagnostics Market: Product Estimates & Trend Analysis
5.1 Transplant Diagnostics Market: Product Movement Analysis
5.2 Reagents and Consumables
5.3 Instrument
5.4 Software and Services

Chapter 6 Transplant Diagnostic Market: Regional Estimates & Trend Analysis, by Technology & Product Type

Chapter 7 Competitive Landscape
7.1 Company Profiles

  • Thermo Fisher Scientific, Inc.
  • QIAGEN
  • Illumina, Inc.
  • F. Hoffmann La-Roche Ltd
  • Abbott
  • Bio-Rad Laboratories Inc.
  • IMMUCOR
  • Omixon Inc.

For more information about this report visit https://www.researchandmarkets.com/research/7tfk7j/global_transplant?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/global-transplant-diagnostics-market-size-share--trends-analysis-report-2018-2024-300705423.html

SOURCE Research and Markets

View Comments and Join the Discussion!